etodolac has been researched along with Cancer of Mouth in 1 studies
Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5-Fluorouracil (5FU) is an effective chemotherapeutic indicated for oral cancer treatment." | 1.72 | Transfersome Hydrogel Containing 5-Fluorouracil and Etodolac Combination for Synergistic Oral Cancer Treatment. ( Bollareddy, SR; Dasari, D; Dhar, A; Krishna, V; Roy, G; Venuganti, VVK, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bollareddy, SR | 1 |
| Krishna, V | 1 |
| Roy, G | 1 |
| Dasari, D | 1 |
| Dhar, A | 1 |
| Venuganti, VVK | 1 |
1 other study available for etodolac and Cancer of Mouth
| Article | Year |
|---|---|
Transfersome Hydrogel Containing 5-Fluorouracil and Etodolac Combination for Synergistic Oral Cancer Treatment.
Topics: Administration, Cutaneous; Animals; Drug Carriers; Etodolac; Fluorouracil; Hydrogels; Liposomes; Mou | 2022 |